IMDX
NASDAQ · Biotechnology
Insight Molecular Diagnostic
$5.90
+0.48 (+8.86%)
Open$5.45
Previous Close$5.42
Day High$6.06
Day Low$5.20
52W High$8.51
52W Low$2.33
Volume—
Avg Volume298.0K
Market Cap176.14M
P/E Ratio—
EPS$-1.48
SectorBiotechnology
Analyst Ratings
Buy
10 analysts
Price Target
+195.1% upside
Current
$5.90
$5.90
Target
$17.41
$17.41
$14.05
$17.41 avg
$26.42
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 4.15M | 2.57M | 22.03M |
| Net Income | -51,374,484 | -28,603,176 | 4.29M |
| Profit Margin | -1,238.5% | -1,176.6% | 19.5% |
| EBITDA | -50,139,925 | -29,466,705 | 9.08M |
| Free Cash Flow | — | — | 3.08M |
| Rev Growth | +61.7% | +61.7% | +9.7% |
| Debt/Equity | — | — | 1.02 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $251.64 | -1.05% | 118.2 | 429.58B |
| AMGN | Amgen Inc | $362.12 | +0.44% | 24.8 | 193.10B |
| GILD | Gilead Sciences Inc | $126.34 | +0.01% | 17.1 | 157.21B |
| VRTX | Vertex Pharmaceuticals Inc | $496.73 | -0.58% | 28.1 | 121.87B |
| REGN | Regeneron Pharmaceuticals | $623.54 | -1.31% | 15.0 | 66.35B |
| ALNY | Alnylam Pharmaceuticals Inc | $301.03 | +2.56% | 69.3 | 39.97B |